Skip to main content
Top
Published in: BMC Surgery 2/2013

Open Access 01-10-2013 | Research article

Prognostic factors in elderly patients with breast cancer

Authors: Alessandro Cappellani, Maria Di Vita, Antonio Zanghì, Andrea Cavallaro, Gaetano Piccolo, Marcello Majorana, Giuseppina Barbera, Massimiliano Berretta

Published in: BMC Surgery | Special Issue 2/2013

Login to get access

Abstract

Background

Breast cancer (BC) remains principally a disease of old ages; with 35-50% of cases occurring in women older than 65 years. Even mortality for cancer increases with aging: 19.7% between 65 and 74 years; 22.6% between 75 and 84 years; and 15.1% in 85 years or more.
The study was aimed to investigate specific predictive factors for elderly patients so to select the best way to treat and follow these patients.

Methods

A search was performed on Medline, Embase, Scopus using the following Key words: Breast cancer, Breast neoplasms, Aged, Elder, Elderly, Eldest, Older, Survival analysis, Prognosis, Prognostic factors, Tumor markers, Biomarkers, Comorbidity, Geriatric assessment, Axilla, Axillary surgery. 3029 studies have been retrieved. Paper in which overall or disease free survival were not end points, or age class was not well defined, or the sample was too small, were excluded. At last 42 papers fulfilled the criteria.

Results and discussion

Lack of screening and delay in diagnosis may be responsible for the minor improvement in survival observed in elderly respect to younger breast cancer patients. Predictive factors are the same and must be assessed with the same attention reserved to younger women.

Conclusions

Most of elderly patient are fit to undergo standard treatment and can get the same benefits of younger women. Nevertheless it is possible that some older women with early breast cancer can be spared too aggressive treatments. Geriatric assessment and co-morbidities can affect the prognosis modifying surveillance, life expectancy and compliance to therapies. They can thus be useful to select the better treatment, either surgical or radio or hormone - or chemo-therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen H-S, Feuer EJ, Cronin K-A: SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). National Cancer Institute Bethesda, MD, Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen H-S, Feuer EJ, Cronin K-A: SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). National Cancer Institute Bethesda, MD,
2.
go back to reference Ali AM, Greenberg D, Wishart GC, Pharoah P: Patient and tumour characteristics, management, and age-specific survival in women with breast cancer in the East of England. Br J Cancer. 2011, 104: 564-570. 10.1038/bjc.2011.14.PubMedCentralCrossRefPubMed Ali AM, Greenberg D, Wishart GC, Pharoah P: Patient and tumour characteristics, management, and age-specific survival in women with breast cancer in the East of England. Br J Cancer. 2011, 104: 564-570. 10.1038/bjc.2011.14.PubMedCentralCrossRefPubMed
3.
go back to reference Lavelle K, Todd C, Moran A, Howell A, Bundred N, Campbell M: Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years. Br J Cancer. 2007, 96: 1197-1203. 10.1038/sj.bjc.6603709.PubMedCentralCrossRefPubMed Lavelle K, Todd C, Moran A, Howell A, Bundred N, Campbell M: Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years. Br J Cancer. 2007, 96: 1197-1203. 10.1038/sj.bjc.6603709.PubMedCentralCrossRefPubMed
4.
go back to reference Associazione Italiana Registri Tumori, Epidemiologia & Prevenzione. 2006, 30 (suppl 2): Associazione Italiana Registri Tumori, Epidemiologia & Prevenzione. 2006, 30 (suppl 2):
5.
go back to reference Wyld L, Garg DK, Kumar ID, Brown H, Reed MW: Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines. Br J Cancer. 2004, 90: 1486-1491. 10.1038/sj.bjc.6601742.PubMedCentralCrossRefPubMed Wyld L, Garg DK, Kumar ID, Brown H, Reed MW: Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines. Br J Cancer. 2004, 90: 1486-1491. 10.1038/sj.bjc.6601742.PubMedCentralCrossRefPubMed
6.
go back to reference Phua CE, Bustam AZ, Yip CH, Taib NA: Prognostic factors for elderly breast cancer patients in University Malaya Medical Centre, Malaysia. Asian Pac J Cancer Prev. 2010, 11: 1205-1211.PubMed Phua CE, Bustam AZ, Yip CH, Taib NA: Prognostic factors for elderly breast cancer patients in University Malaya Medical Centre, Malaysia. Asian Pac J Cancer Prev. 2010, 11: 1205-1211.PubMed
7.
go back to reference Williams BA, Lindquist K, Sudore RL, Covinsky KE, Walter LC: Screening mammography in older women. Effect of wealth and prognosis. Arch Intern Med. 2008, 168: 514-520. 10.1001/archinternmed.2007.103.CrossRefPubMed Williams BA, Lindquist K, Sudore RL, Covinsky KE, Walter LC: Screening mammography in older women. Effect of wealth and prognosis. Arch Intern Med. 2008, 168: 514-520. 10.1001/archinternmed.2007.103.CrossRefPubMed
8.
go back to reference Chatzidaki P, Mellos C, Briese V, Mylonas I: Does primary breast cancer in older women (≥80 years) have unfavorable histological characteristics?. Arch Gynecol Obstet. 2011, 284: 705-712. 10.1007/s00404-010-1697-5.CrossRefPubMed Chatzidaki P, Mellos C, Briese V, Mylonas I: Does primary breast cancer in older women (≥80 years) have unfavorable histological characteristics?. Arch Gynecol Obstet. 2011, 284: 705-712. 10.1007/s00404-010-1697-5.CrossRefPubMed
9.
go back to reference Serra R, Buffone G, Perri P, Renne M, Amato B, de Franciscis S: Male breast cancer manifesting as Cephalic Vein Thrombosis in a 70-year-old patient. Ann Vasc Surg. 2013, Serra R, Buffone G, Perri P, Renne M, Amato B, de Franciscis S: Male breast cancer manifesting as Cephalic Vein Thrombosis in a 70-year-old patient. Ann Vasc Surg. 2013,
10.
go back to reference van de Water W, Markopoulos C, van de Velde CJ, Seynaeve C, Hasenburg A, Rea D, Putter H, Nortier JW, de Craen AJ, Hille ET, Bastiaannet E, Hadji P, Westendorp RG, Liefers GJ, Jones SE: Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA. 2012, 8 (307): 590-597. van de Water W, Markopoulos C, van de Velde CJ, Seynaeve C, Hasenburg A, Rea D, Putter H, Nortier JW, de Craen AJ, Hille ET, Bastiaannet E, Hadji P, Westendorp RG, Liefers GJ, Jones SE: Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA. 2012, 8 (307): 590-597.
11.
go back to reference Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA: Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet. 1999, 353: 1127-1131. 10.1016/S0140-6736(99)02142-X.CrossRefPubMed Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA: Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet. 1999, 353: 1127-1131. 10.1016/S0140-6736(99)02142-X.CrossRefPubMed
12.
go back to reference Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD: The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br Journal of Cancer. 1999, 79: 858-864. 10.1038/sj.bjc.6690137.CrossRef Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD: The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br Journal of Cancer. 1999, 79: 858-864. 10.1038/sj.bjc.6690137.CrossRef
13.
go back to reference Leonard R, Ballinger R, Cameron D, Ellis P, Fallowfield L, Gosney M, Johnson L, Kilburn LS, Makris A, Mansi J, Reed M, Ring A, Robinson A, Simmonds P, Thomas G, Bliss JM: Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase?. Br J Cancer. 2011, 105: 1260-1266. 10.1038/bjc.2011.377.PubMedCentralCrossRefPubMed Leonard R, Ballinger R, Cameron D, Ellis P, Fallowfield L, Gosney M, Johnson L, Kilburn LS, Makris A, Mansi J, Reed M, Ring A, Robinson A, Simmonds P, Thomas G, Bliss JM: Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase?. Br J Cancer. 2011, 105: 1260-1266. 10.1038/bjc.2011.377.PubMedCentralCrossRefPubMed
14.
go back to reference Solej M, Sanguinett A, Ragusa M, de Falco M, Sperlongano P, Calzolari F, Parmeggiani D, Misso C, Piatto A, Parmeggiani U, Avenia N: Locally advanced breast cancer in elderly patients: treatment standardised or tailored to individual needs?. Chirurgia Italiana. 2007, 59: 829-833. Solej M, Sanguinett A, Ragusa M, de Falco M, Sperlongano P, Calzolari F, Parmeggiani D, Misso C, Piatto A, Parmeggiani U, Avenia N: Locally advanced breast cancer in elderly patients: treatment standardised or tailored to individual needs?. Chirurgia Italiana. 2007, 59: 829-833.
15.
go back to reference Di Vita M, Berretta M, Zanghi A, Cacopardo B, Cavallaro A, Lombardi D, Lo Menzo E, Cappellani A: Bioclinical markers in breast cancer: updates and perspectives. Front Biosci (Schol Ed). 2010, 2: 343-358.CrossRef Di Vita M, Berretta M, Zanghi A, Cacopardo B, Cavallaro A, Lombardi D, Lo Menzo E, Cappellani A: Bioclinical markers in breast cancer: updates and perspectives. Front Biosci (Schol Ed). 2010, 2: 343-358.CrossRef
16.
go back to reference Martelli G, Boracchi P, de Palo M, Pilotti S, Oriana S, Zucali R, Daidone MG, De Palo G: A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up. Ann Surg. 2005, 242: 1-6. 10.1097/01.sla.0000167759.15670.14. discussion 7-9PubMedCentralCrossRefPubMed Martelli G, Boracchi P, de Palo M, Pilotti S, Oriana S, Zucali R, Daidone MG, De Palo G: A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up. Ann Surg. 2005, 242: 1-6. 10.1097/01.sla.0000167759.15670.14. discussion 7-9PubMedCentralCrossRefPubMed
17.
go back to reference Martelli G, Miceli R, Daidone MG, Vetrella G, Cerrotta AM, Piromalli D, Agresti R: Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol. 2011, 18: 125-133. 10.1245/s10434-010-1217-7.PubMedCentralCrossRefPubMed Martelli G, Miceli R, Daidone MG, Vetrella G, Cerrotta AM, Piromalli D, Agresti R: Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol. 2011, 18: 125-133. 10.1245/s10434-010-1217-7.PubMedCentralCrossRefPubMed
18.
go back to reference Albrand G, Terret C: Early breast cancer in the elderly: assessment and management considerations. Drugs Aging. 2008, 25: 35-45. 10.2165/00002512-200825010-00004.CrossRefPubMed Albrand G, Terret C: Early breast cancer in the elderly: assessment and management considerations. Drugs Aging. 2008, 25: 35-45. 10.2165/00002512-200825010-00004.CrossRefPubMed
19.
go back to reference Audisio RA, Bozzetti F, Gennari R, Jaklitsch MT, Koperna T, Longo WE, Wiggers T, Zbar AP: The surgical management of elderly cancer patients; recommendations of the SIOG surgical task force. Eur J Cancer. 2004, 40: 926-938. 10.1016/j.ejca.2004.01.016.CrossRefPubMed Audisio RA, Bozzetti F, Gennari R, Jaklitsch MT, Koperna T, Longo WE, Wiggers T, Zbar AP: The surgical management of elderly cancer patients; recommendations of the SIOG surgical task force. Eur J Cancer. 2004, 40: 926-938. 10.1016/j.ejca.2004.01.016.CrossRefPubMed
20.
go back to reference Hieken TJ, Nettnin S, Velasco JM: The value of sentinel lymph node biopsy in elderly breast cancer patients. Am J Surg. 2004, 188: 440-442. 10.1016/j.amjsurg.2004.06.028.CrossRefPubMed Hieken TJ, Nettnin S, Velasco JM: The value of sentinel lymph node biopsy in elderly breast cancer patients. Am J Surg. 2004, 188: 440-442. 10.1016/j.amjsurg.2004.06.028.CrossRefPubMed
21.
go back to reference Gennari R, Curigliano G, Rotmensz N, Robertson C, Colleoni M, Zurrida S, Nol F, de Braud F, Orlando L, Leonardi MC, Galimberti V, Intra M, Veronesi P, Renne G, Cinieri S, Audisio RA, Luini A, Orecchia R, Viale G, Goldhirsch A: Breast carcinoma in elderly women. Cancer. 2004, 101: 1302-1310. 10.1002/cncr.20535.CrossRefPubMed Gennari R, Curigliano G, Rotmensz N, Robertson C, Colleoni M, Zurrida S, Nol F, de Braud F, Orlando L, Leonardi MC, Galimberti V, Intra M, Veronesi P, Renne G, Cinieri S, Audisio RA, Luini A, Orecchia R, Viale G, Goldhirsch A: Breast carcinoma in elderly women. Cancer. 2004, 101: 1302-1310. 10.1002/cncr.20535.CrossRefPubMed
22.
go back to reference Kohrt HE, Olshen RA, Bermas HR, Goodson WH, Wood DJ, Henry S, Rouse RV, Bailey L, Philben VJ, Dirbas FM, Dunn JJ, Johnson DL, Wapnir IL, Carlson RW, Stockdale FE, Hansen NM, Jeffrey SS: New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer. 2008, 8: 66-10.1186/1471-2407-8-66. Bay Area SLN StudyPubMedCentralCrossRefPubMed Kohrt HE, Olshen RA, Bermas HR, Goodson WH, Wood DJ, Henry S, Rouse RV, Bailey L, Philben VJ, Dirbas FM, Dunn JJ, Johnson DL, Wapnir IL, Carlson RW, Stockdale FE, Hansen NM, Jeffrey SS: New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer. 2008, 8: 66-10.1186/1471-2407-8-66. Bay Area SLN StudyPubMedCentralCrossRefPubMed
23.
go back to reference Biganzoli L, Wildiers H, Oakman C, Marotti L, Loibl S, Kunkler I, Reed M, Ciatto S, Voogd AC, Brain E, Cutuli B, Terret C, Gosney M, Aapro M, Audisio R: Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol. 2012, 13 (4): e148-e160. 10.1016/S1470-2045(11)70383-7. AprCrossRefPubMed Biganzoli L, Wildiers H, Oakman C, Marotti L, Loibl S, Kunkler I, Reed M, Ciatto S, Voogd AC, Brain E, Cutuli B, Terret C, Gosney M, Aapro M, Audisio R: Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol. 2012, 13 (4): e148-e160. 10.1016/S1470-2045(11)70383-7. AprCrossRefPubMed
24.
go back to reference Wildiers H, Kunkler I, Biganzoli L, Fracheboud J, Vlastos G, Bernard-Marty C, Hurria A, Extermann M, Girre V, Brain E, Audisio RA, Bartelink H, Barton M, Giordano SH, Muss H, Aapro M: Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol. 2007, 8 (12): 1101-1115. 10.1016/S1470-2045(07)70378-9. International Society of Geriatric OncologyCrossRefPubMed Wildiers H, Kunkler I, Biganzoli L, Fracheboud J, Vlastos G, Bernard-Marty C, Hurria A, Extermann M, Girre V, Brain E, Audisio RA, Bartelink H, Barton M, Giordano SH, Muss H, Aapro M: Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol. 2007, 8 (12): 1101-1115. 10.1016/S1470-2045(07)70378-9. International Society of Geriatric OncologyCrossRefPubMed
25.
go back to reference Lyman GH, Giuliano AE, Somerfield MR, Benson AB, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005, 23: 7703-7720. 10.1200/JCO.2005.08.001. American Society of Clinical OncologyCrossRefPubMed Lyman GH, Giuliano AE, Somerfield MR, Benson AB, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005, 23: 7703-7720. 10.1200/JCO.2005.08.001. American Society of Clinical OncologyCrossRefPubMed
26.
go back to reference Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE: Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?. Ann Surg. 1999, 229: 536-541. 10.1097/00000658-199904000-00013.PubMedCentralCrossRefPubMed Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE: Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?. Ann Surg. 1999, 229: 536-541. 10.1097/00000658-199904000-00013.PubMedCentralCrossRefPubMed
27.
go back to reference Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, Borgen PI, Cody HS, Kattan MW: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003, 10: 1140-1151. 10.1245/ASO.2003.03.015.CrossRefPubMed Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, Borgen PI, Cody HS, Kattan MW: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003, 10: 1140-1151. 10.1245/ASO.2003.03.015.CrossRefPubMed
28.
go back to reference Smidt ML, Kuster DM, van der Wilt GJ, Thunnissen FB, Van Zee KJ, Strobbe LJ: Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in the Netherlands?. Ann Surg Oncol. 2005, 12: 1066-1072. 10.1245/ASO.2005.07.022.CrossRefPubMed Smidt ML, Kuster DM, van der Wilt GJ, Thunnissen FB, Van Zee KJ, Strobbe LJ: Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in the Netherlands?. Ann Surg Oncol. 2005, 12: 1066-1072. 10.1245/ASO.2005.07.022.CrossRefPubMed
29.
go back to reference Orsoni M, Clerc J, Golfier F, Cortet M, Raudrant D, Krauth JS: Axillary lymph node dissection in the case of sentinel lymph node micrometastatic invasion: evaluation of three predictive models. Eur J Obstet Gynecol Reprod Biol. 2011, 158: 334-337. 10.1016/j.ejogrb.2011.05.020.CrossRefPubMed Orsoni M, Clerc J, Golfier F, Cortet M, Raudrant D, Krauth JS: Axillary lymph node dissection in the case of sentinel lymph node micrometastatic invasion: evaluation of three predictive models. Eur J Obstet Gynecol Reprod Biol. 2011, 158: 334-337. 10.1016/j.ejogrb.2011.05.020.CrossRefPubMed
30.
go back to reference Gur AS, Unal B, Ozbek U, Ozmen V, Aydogan F, Gokgoz S, Gulluoglu BM, Aksaz E, Ozbas S, Baskan S, Koyuncu A, Soran A: Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study. Eur J Surg Oncol. 2010, 36: 30-35. 10.1016/j.ejso.2009.05.007. Turkish Federation of Breast Disease Associations Protocol MF08-01 investigators.CrossRefPubMed Gur AS, Unal B, Ozbek U, Ozmen V, Aydogan F, Gokgoz S, Gulluoglu BM, Aksaz E, Ozbas S, Baskan S, Koyuncu A, Soran A: Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study. Eur J Surg Oncol. 2010, 36: 30-35. 10.1016/j.ejso.2009.05.007. Turkish Federation of Breast Disease Associations Protocol MF08-01 investigators.CrossRefPubMed
31.
go back to reference Pal A, Provenzano E, Duffy SW, Pinder SE, Purushotham AD: A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg. 2008, 95: 302-309. 10.1002/bjs.5943.CrossRefPubMed Pal A, Provenzano E, Duffy SW, Pinder SE, Purushotham AD: A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg. 2008, 95: 302-309. 10.1002/bjs.5943.CrossRefPubMed
32.
go back to reference Ponzone R, Maggiorotto F, Mariani L, Jacomuzzi ME, Magistris A, Mininanni P, Biglia N, Sismondi P: Comparison of two models for the prediction of nonsentinel node metastases in breast cancer. Am J Surg. 2007, 193: 686-692. 10.1016/j.amjsurg.2006.09.031.CrossRefPubMed Ponzone R, Maggiorotto F, Mariani L, Jacomuzzi ME, Magistris A, Mininanni P, Biglia N, Sismondi P: Comparison of two models for the prediction of nonsentinel node metastases in breast cancer. Am J Surg. 2007, 193: 686-692. 10.1016/j.amjsurg.2006.09.031.CrossRefPubMed
33.
go back to reference Alran S, de Rycke Y, Fourchotte V, Charitansky H, Laki F, Falcou MC, Benamor M, Freneaux P, Salmon RJ, Sigal-Zafrani B: Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol. 2007, 14: 2195-2201. 10.1245/s10434-006-9331-2. Institut Curie Breast Cancer Study GroupCrossRefPubMed Alran S, de Rycke Y, Fourchotte V, Charitansky H, Laki F, Falcou MC, Benamor M, Freneaux P, Salmon RJ, Sigal-Zafrani B: Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol. 2007, 14: 2195-2201. 10.1245/s10434-006-9331-2. Institut Curie Breast Cancer Study GroupCrossRefPubMed
34.
go back to reference Sasada T, Murakami S, Kataoka T, Ohara M, Ozaki S, Okada M, Ohdan H: Nomogram to predict the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients. Surg Today. 2012, 42: 245-249. 10.1007/s00595-011-0088-2. Memorial Sloan-Kettering Cancer CenterCrossRefPubMed Sasada T, Murakami S, Kataoka T, Ohara M, Ozaki S, Okada M, Ohdan H: Nomogram to predict the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients. Surg Today. 2012, 42: 245-249. 10.1007/s00595-011-0088-2. Memorial Sloan-Kettering Cancer CenterCrossRefPubMed
35.
go back to reference Moghaddam Y, Falzon M, Fulford L, Williams NR, Keshtgar MR: Comparison of three mathematical models for predicting the risk of additional axillary nodal metastases after positive sentinel lymph node biopsy in early breast cancer. Br J Surg. 2010, 97: 1646-1652. 10.1002/bjs.7181.CrossRefPubMed Moghaddam Y, Falzon M, Fulford L, Williams NR, Keshtgar MR: Comparison of three mathematical models for predicting the risk of additional axillary nodal metastases after positive sentinel lymph node biopsy in early breast cancer. Br J Surg. 2010, 97: 1646-1652. 10.1002/bjs.7181.CrossRefPubMed
36.
go back to reference D’Eredità G, Troilo VL, Giardina C, Napoli A, Rubini G, Fischetti F, Berardi T: Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms. Clin Breast Cancer. 2010, 10: 445-451. 10.3816/CBC.2010.n.058.CrossRefPubMed D’Eredità G, Troilo VL, Giardina C, Napoli A, Rubini G, Fischetti F, Berardi T: Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms. Clin Breast Cancer. 2010, 10: 445-451. 10.3816/CBC.2010.n.058.CrossRefPubMed
37.
go back to reference van den Hoven I, Kuijt GP, Voogd AC, van Beek MW, Roumen RM: Value of Memorial Sloan-Kettering Cancer Center nomogram in clinical decision making for sentinel lymph node-positive breast cancer. Br J Surg. 2010, 97: 1653-1658. 10.1002/bjs.7186.CrossRefPubMed van den Hoven I, Kuijt GP, Voogd AC, van Beek MW, Roumen RM: Value of Memorial Sloan-Kettering Cancer Center nomogram in clinical decision making for sentinel lymph node-positive breast cancer. Br J Surg. 2010, 97: 1653-1658. 10.1002/bjs.7186.CrossRefPubMed
38.
go back to reference Klar M, Jochmann A, Foeldi M, Stumpf M, Gitsch G, Stickeler E, Watermann D: The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population. Breast Cancer Res Treat. 2008, 112: 523-531. 10.1007/s10549-007-9884-1.CrossRefPubMed Klar M, Jochmann A, Foeldi M, Stumpf M, Gitsch G, Stickeler E, Watermann D: The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population. Breast Cancer Res Treat. 2008, 112: 523-531. 10.1007/s10549-007-9884-1.CrossRefPubMed
39.
go back to reference Hidar S, Harrabi I, Benregaya L, Fatnassi R, Khelifi A, Benabdelkader A, Trabelsi A, Bouaouina N, Ben Ahmed S, Bib M, Khaïri H: Validation of nomograms to predict the risk of non-sentinels lymph node metastases in North African Tunisian breast cancer patients with sentinel node involvement. Breast. 2011, 20: 26-30. 10.1016/j.breast.2010.07.006.CrossRefPubMed Hidar S, Harrabi I, Benregaya L, Fatnassi R, Khelifi A, Benabdelkader A, Trabelsi A, Bouaouina N, Ben Ahmed S, Bib M, Khaïri H: Validation of nomograms to predict the risk of non-sentinels lymph node metastases in North African Tunisian breast cancer patients with sentinel node involvement. Breast. 2011, 20: 26-30. 10.1016/j.breast.2010.07.006.CrossRefPubMed
40.
go back to reference Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, Yi M, Meric-Bernstam F, Ross MI, Babiera GV, Kuerer HM, Hwang RF: Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg Oncol. 2012, 255: 109-115. 10.1097/SLA.0b013e318238f461.CrossRef Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, Yi M, Meric-Bernstam F, Ross MI, Babiera GV, Kuerer HM, Hwang RF: Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg Oncol. 2012, 255: 109-115. 10.1097/SLA.0b013e318238f461.CrossRef
41.
go back to reference Barranger E, Coutant C, Flahault A, Delpech Y, Darai E, Uzan S: An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat. 2005, 91: 113-119. 10.1007/s10549-004-5781-z.CrossRefPubMed Barranger E, Coutant C, Flahault A, Delpech Y, Darai E, Uzan S: An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat. 2005, 91: 113-119. 10.1007/s10549-004-5781-z.CrossRefPubMed
42.
go back to reference Coutant C, Rouzier R, Fondrinier E, Marchal F, Guillemin F, Seince N, Rodrigues A, Darai E, Uzan S, Barranger E: Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study. Breast Cancer Res Treat. 2009, 113: 537-543. 10.1007/s10549-008-9967-7.CrossRefPubMed Coutant C, Rouzier R, Fondrinier E, Marchal F, Guillemin F, Seince N, Rodrigues A, Darai E, Uzan S, Barranger E: Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study. Breast Cancer Res Treat. 2009, 113: 537-543. 10.1007/s10549-008-9967-7.CrossRefPubMed
43.
go back to reference Andersson Y, Frisell J, de Boniface J, Bergkvist L: Prediction of non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastases: evaluation of the tenon score. Breast Cancer (Auck). 2012, 6: 31-38. Andersson Y, Frisell J, de Boniface J, Bergkvist L: Prediction of non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastases: evaluation of the tenon score. Breast Cancer (Auck). 2012, 6: 31-38.
44.
go back to reference Unal B, Gur AS, Ahrendt G, Johnson R, Bonaventura M, Soran A: Can nomograms predict non-sentinel lymph node metastasis after neoadjuvant chemotherapy in sentinel lymph node-positive breast cancer patients?. Clin Breast Cancer. 2009, 9: 92-95. 10.3816/CBC.2009.n.017.CrossRefPubMed Unal B, Gur AS, Ahrendt G, Johnson R, Bonaventura M, Soran A: Can nomograms predict non-sentinel lymph node metastasis after neoadjuvant chemotherapy in sentinel lymph node-positive breast cancer patients?. Clin Breast Cancer. 2009, 9: 92-95. 10.3816/CBC.2009.n.017.CrossRefPubMed
45.
go back to reference Chagpar AB, McMasters KM, Edwards MJ: Can sentinel node biopsy be avoided in some elderly breast cancer patients?. Ann Surg. 2009, 249: 455-460. 10.1097/SLA.0b013e318194d16b. North American Fareston Tamoxifen Adjuvant TrialCrossRefPubMed Chagpar AB, McMasters KM, Edwards MJ: Can sentinel node biopsy be avoided in some elderly breast cancer patients?. Ann Surg. 2009, 249: 455-460. 10.1097/SLA.0b013e318194d16b. North American Fareston Tamoxifen Adjuvant TrialCrossRefPubMed
46.
go back to reference Chagpar AB, Scoggins CR, Martin RC, Sahoo S, Carlson DJ, Laidley AL, El-Eid SE, McGlothin TQ, McMasters KM: Factors determining adequacy of axillary node dissection in breast cancer patients. Breast J. 2007, 13: 233-237. 10.1111/j.1524-4741.2007.00415.x. University of Louisville Breast Sentinel Lymph Node StudyCrossRefPubMed Chagpar AB, Scoggins CR, Martin RC, Sahoo S, Carlson DJ, Laidley AL, El-Eid SE, McGlothin TQ, McMasters KM: Factors determining adequacy of axillary node dissection in breast cancer patients. Breast J. 2007, 13: 233-237. 10.1111/j.1524-4741.2007.00415.x. University of Louisville Breast Sentinel Lymph Node StudyCrossRefPubMed
47.
go back to reference Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989, 63: 181-187. 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H.CrossRefPubMed Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989, 63: 181-187. 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H.CrossRefPubMed
48.
go back to reference Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O’Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ: Prognostic factors in breast cancer College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000, 124: 966-978.PubMed Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O’Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ: Prognostic factors in breast cancer College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000, 124: 966-978.PubMed
49.
go back to reference Somner JE, Dixon JM, Thomas JS: Node retrieval in axillary lymph node dissections: recommendations for minimum numbers to be confident about node negative status. J Clin Pathol. 2004, 57: 845-848. 10.1136/jcp.2003.015560.PubMedCentralCrossRefPubMed Somner JE, Dixon JM, Thomas JS: Node retrieval in axillary lymph node dissections: recommendations for minimum numbers to be confident about node negative status. J Clin Pathol. 2004, 57: 845-848. 10.1136/jcp.2003.015560.PubMedCentralCrossRefPubMed
50.
go back to reference Ahn SH, Kim HJ, Lee JW, Gong GY, Noh DY, Yang JH, Jung SS, Park HY: Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society. Breast Cancer Res Treat. 2011, 130: 507-515. 10.1007/s10549-011-1730-9.CrossRefPubMed Ahn SH, Kim HJ, Lee JW, Gong GY, Noh DY, Yang JH, Jung SS, Park HY: Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society. Breast Cancer Res Treat. 2011, 130: 507-515. 10.1007/s10549-011-1730-9.CrossRefPubMed
51.
go back to reference Amato B, Rispoli C, Iannone L, Testa S, Compagna R, Rocco N: Surgical margins of resection for breast cancer: Current evidence. Minerva Chirurgica. 2012, 67 (5): 445-452.PubMed Amato B, Rispoli C, Iannone L, Testa S, Compagna R, Rocco N: Surgical margins of resection for breast cancer: Current evidence. Minerva Chirurgica. 2012, 67 (5): 445-452.PubMed
52.
go back to reference Solej M, Ferronato M, Nano M: Locally advanced breast cancer in the elderly: curettage mastectomy. Tumori. 2005, 91: 321-324.PubMed Solej M, Ferronato M, Nano M: Locally advanced breast cancer in the elderly: curettage mastectomy. Tumori. 2005, 91: 321-324.PubMed
53.
go back to reference Wasuthit Y, Kongdan Y, Suvikapakornkul R, Lertsithichai P, Chirappapha P: Predictive factors of axillary lymph node metastasis in breast cancer. J Med Assoc Thai. 2011, 94: 65-70.PubMed Wasuthit Y, Kongdan Y, Suvikapakornkul R, Lertsithichai P, Chirappapha P: Predictive factors of axillary lymph node metastasis in breast cancer. J Med Assoc Thai. 2011, 94: 65-70.PubMed
54.
go back to reference Ejlertsen B, Jensen MB, Rank F, Rasmussen BB, Christiansen P, Kroman N, Kvistgaard ME, Overgaard M, Toftdahl DB, Mouridsen HT: Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer. J Natl Cancer Inst. 2009, 101: 729-735. 10.1093/jnci/djp090. Danish Breast Cancer Cooperative GroupCrossRefPubMed Ejlertsen B, Jensen MB, Rank F, Rasmussen BB, Christiansen P, Kroman N, Kvistgaard ME, Overgaard M, Toftdahl DB, Mouridsen HT: Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer. J Natl Cancer Inst. 2009, 101: 729-735. 10.1093/jnci/djp090. Danish Breast Cancer Cooperative GroupCrossRefPubMed
55.
go back to reference Ramjeesingh R, Quan ML, Gardner S, Holloway CM: Prediction of involvement of sentinel and nonsentinel lymph nodes in a Canadian population with breast cancer. Can J Surg. 2009, 52: 23-30.PubMedCentralPubMed Ramjeesingh R, Quan ML, Gardner S, Holloway CM: Prediction of involvement of sentinel and nonsentinel lymph nodes in a Canadian population with breast cancer. Can J Surg. 2009, 52: 23-30.PubMedCentralPubMed
56.
go back to reference Gennari R, Rotmensz N, Perego E, dos Santos G, Veronesi U: Sentinel node biopsy in elderly breast cancer patients. Surg Oncol. 2004, 13: 193-196. 10.1016/j.suronc.2004.08.011.CrossRefPubMed Gennari R, Rotmensz N, Perego E, dos Santos G, Veronesi U: Sentinel node biopsy in elderly breast cancer patients. Surg Oncol. 2004, 13: 193-196. 10.1016/j.suronc.2004.08.011.CrossRefPubMed
57.
go back to reference Osborn G, Jones M, Champ C, Gower-Thomas K, Vaughan-Williams E: Is primary endocrine therapy effective in treating the elderly, unfit patient with breast cancer?. Ann R Coll Surg Engl. 2011, 93: 286-289. 10.1308/003588411X571917.PubMedCentralCrossRefPubMed Osborn G, Jones M, Champ C, Gower-Thomas K, Vaughan-Williams E: Is primary endocrine therapy effective in treating the elderly, unfit patient with breast cancer?. Ann R Coll Surg Engl. 2011, 93: 286-289. 10.1308/003588411X571917.PubMedCentralCrossRefPubMed
58.
go back to reference Poltinnikov IM, Rudoler SB, Tymofyeyev Y, Kennedy J, Anne PR, Curran WJ: Impact of Her-2 Neu overexpression on outcome of elderly women treated with wide local excision and breast irradiation for early stage breast cancer: an exploratory analysis. Am J Clin Oncol. 2006, 29: 71-79. 10.1097/01.coc.0000197696.48980.11.CrossRefPubMed Poltinnikov IM, Rudoler SB, Tymofyeyev Y, Kennedy J, Anne PR, Curran WJ: Impact of Her-2 Neu overexpression on outcome of elderly women treated with wide local excision and breast irradiation for early stage breast cancer: an exploratory analysis. Am J Clin Oncol. 2006, 29: 71-79. 10.1097/01.coc.0000197696.48980.11.CrossRefPubMed
59.
go back to reference Durbecq V, Ameye L, Veys I, Paesmans M, Desmedt C, Sirtaine N, Sotiriou C, Bernard-Marty C, Nogaret JM, Piccart M, Larsimont D: A significant proportion of elderly patients develop hormone-dependant "luminal-B" tumours associated with aggressive characteristics. Crit Rev Oncol Hematol. 2008, 67 (1): 80-92. 10.1016/j.critrevonc.2007.12.008. JulCrossRefPubMed Durbecq V, Ameye L, Veys I, Paesmans M, Desmedt C, Sirtaine N, Sotiriou C, Bernard-Marty C, Nogaret JM, Piccart M, Larsimont D: A significant proportion of elderly patients develop hormone-dependant "luminal-B" tumours associated with aggressive characteristics. Crit Rev Oncol Hematol. 2008, 67 (1): 80-92. 10.1016/j.critrevonc.2007.12.008. JulCrossRefPubMed
60.
go back to reference Lowery JT, Byers T, Kittelson J, Hokanson JE, Mouchawar J, Lewin J, Merrick D, Hines L, Singh M: Differential expression of prognostic biomarkers between interval and screen-detected breast cancers: does age or family history matter?. Breast Cancer Res Treat. 2011, 129: 211-219. 10.1007/s10549-011-1448-8.CrossRefPubMed Lowery JT, Byers T, Kittelson J, Hokanson JE, Mouchawar J, Lewin J, Merrick D, Hines L, Singh M: Differential expression of prognostic biomarkers between interval and screen-detected breast cancers: does age or family history matter?. Breast Cancer Res Treat. 2011, 129: 211-219. 10.1007/s10549-011-1448-8.CrossRefPubMed
61.
go back to reference Yildirim Y, Gunel N, Coskun U, Pasaoglu H, Aslan S, Cetin A: Serum neopterin levels in patients with breast cancer. Med Oncol. 2008, 25: 403-407. 10.1007/s12032-008-9054-2.CrossRefPubMed Yildirim Y, Gunel N, Coskun U, Pasaoglu H, Aslan S, Cetin A: Serum neopterin levels in patients with breast cancer. Med Oncol. 2008, 25: 403-407. 10.1007/s12032-008-9054-2.CrossRefPubMed
62.
go back to reference Melicharovà K, Kalàbovà H, Krcmovà L, Urbànek L, Solichovà D, Melichar B: Effect of comorbidity on urinary neopterin in patients with breast carcinoma. Eur J Cancer Care (English Ed online). 2010, 19: 340-345. 10.1111/j.1365-2354.2008.01058.x.CrossRef Melicharovà K, Kalàbovà H, Krcmovà L, Urbànek L, Solichovà D, Melichar B: Effect of comorbidity on urinary neopterin in patients with breast carcinoma. Eur J Cancer Care (English Ed online). 2010, 19: 340-345. 10.1111/j.1365-2354.2008.01058.x.CrossRef
63.
go back to reference Schrauder MG, Fasching PA, Häberle L, Lux MP, Rauh C, Hein A, Bayer CM, Heusinger K, Hartmann A, Strehl JD, Wachter DL, Schulz-Wendtland R, Adamietz B, Beckmann MW, Loehberg CR: Diabetes and prognosis in a breast cancer cohort. J Cancer Res Clin Oncol. 2011, 137 (6): 975-983. 10.1007/s00432-010-0960-2. JunCrossRefPubMed Schrauder MG, Fasching PA, Häberle L, Lux MP, Rauh C, Hein A, Bayer CM, Heusinger K, Hartmann A, Strehl JD, Wachter DL, Schulz-Wendtland R, Adamietz B, Beckmann MW, Loehberg CR: Diabetes and prognosis in a breast cancer cohort. J Cancer Res Clin Oncol. 2011, 137 (6): 975-983. 10.1007/s00432-010-0960-2. JunCrossRefPubMed
64.
go back to reference Cappellani A, Di Vita M, Zanghi A, Cavallaro A, Piccolo G, Veroux M, Berretta M, Malaguarnera M, Canzonieri V, Lo Menzo E: Diet, obesity and breast cancer: an update. Front Biosci (Schol Ed). 2012, 4: 90-108. Jan 1CrossRef Cappellani A, Di Vita M, Zanghi A, Cavallaro A, Piccolo G, Veroux M, Berretta M, Malaguarnera M, Canzonieri V, Lo Menzo E: Diet, obesity and breast cancer: an update. Front Biosci (Schol Ed). 2012, 4: 90-108. Jan 1CrossRef
65.
go back to reference Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL: Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer. 2001, 92 (4): 720-729. 10.1002/1097-0142(20010815)92:4<720::AID-CNCR1375>3.0.CO;2-T.CrossRefPubMed Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL: Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer. 2001, 92 (4): 720-729. 10.1002/1097-0142(20010815)92:4<720::AID-CNCR1375>3.0.CO;2-T.CrossRefPubMed
66.
go back to reference Jung SY, Rosenzweig M, Linkov F, Brufsky A, Weissfeld JL, Sereika SM: Comorbidity as a mediator of survival disparity between younger and older women diagnosed with metastatic breast cancer. Hypertension. 2012, 59: 205-211. 10.1161/HYPERTENSIONAHA.111.171736.CrossRefPubMed Jung SY, Rosenzweig M, Linkov F, Brufsky A, Weissfeld JL, Sereika SM: Comorbidity as a mediator of survival disparity between younger and older women diagnosed with metastatic breast cancer. Hypertension. 2012, 59: 205-211. 10.1161/HYPERTENSIONAHA.111.171736.CrossRefPubMed
67.
go back to reference Extermann M, Hurria A: Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007, 25: 1824-1831. 10.1200/JCO.2007.10.6559.CrossRefPubMed Extermann M, Hurria A: Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007, 25: 1824-1831. 10.1200/JCO.2007.10.6559.CrossRefPubMed
68.
go back to reference Repetto L, Fratino L, Audisio RA, Venturino A, Gianni W, Vercelli M, Parodi S, Dal Lago D, Gioia F, Monfardini S, Aapro MS, Serraino D, Zagonel V: Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002, 20: 494-502. 10.1200/JCO.20.2.494.CrossRefPubMed Repetto L, Fratino L, Audisio RA, Venturino A, Gianni W, Vercelli M, Parodi S, Dal Lago D, Gioia F, Monfardini S, Aapro MS, Serraino D, Zagonel V: Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002, 20: 494-502. 10.1200/JCO.20.2.494.CrossRefPubMed
69.
go back to reference Clough-Gorr KM, Stuck AE, Thwin SS, Silliman RA: Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up. J Clin Oncol. 2010, 28: 380-386. 10.1200/JCO.2009.23.5440.PubMedCentralCrossRefPubMed Clough-Gorr KM, Stuck AE, Thwin SS, Silliman RA: Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up. J Clin Oncol. 2010, 28: 380-386. 10.1200/JCO.2009.23.5440.PubMedCentralCrossRefPubMed
70.
go back to reference Fiorica F, Berretta M, Ursino S, Fisichella R, Lleshi A, Fiorica G, Stefanelli A, Zini G, Tirelli U, Zanghi A, Cappellani A, Berretta S, Cartei F: Adjuvant radiotherapy on older and oldest breast cancer patients after conservative surgery: A retrospective analysis. Arch Gerontol Geriatr. 2012, 55 (2): 283-288. 10.1016/j.archger.2011.10.002. SepCrossRefPubMed Fiorica F, Berretta M, Ursino S, Fisichella R, Lleshi A, Fiorica G, Stefanelli A, Zini G, Tirelli U, Zanghi A, Cappellani A, Berretta S, Cartei F: Adjuvant radiotherapy on older and oldest breast cancer patients after conservative surgery: A retrospective analysis. Arch Gerontol Geriatr. 2012, 55 (2): 283-288. 10.1016/j.archger.2011.10.002. SepCrossRefPubMed
71.
go back to reference Charlson M, Szatrowski TP, Peterson J, Gold J: Validation of a combined comorbidity index. J Clin Epidemiol. 1994, 47: 1245-1251. 10.1016/0895-4356(94)90129-5.CrossRefPubMed Charlson M, Szatrowski TP, Peterson J, Gold J: Validation of a combined comorbidity index. J Clin Epidemiol. 1994, 47: 1245-1251. 10.1016/0895-4356(94)90129-5.CrossRefPubMed
72.
go back to reference Satariano WA, Ragland DR: The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994, 120: 104-110. 10.7326/0003-4819-120-2-199401150-00002.CrossRefPubMed Satariano WA, Ragland DR: The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994, 120: 104-110. 10.7326/0003-4819-120-2-199401150-00002.CrossRefPubMed
73.
go back to reference Patnaik JL, Byers T, Di Guiseppi C, Denberg TD, Dabelea D: The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst. 2011, 103: 1101-1111. 10.1093/jnci/djr188.PubMedCentralCrossRefPubMed Patnaik JL, Byers T, Di Guiseppi C, Denberg TD, Dabelea D: The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst. 2011, 103: 1101-1111. 10.1093/jnci/djr188.PubMedCentralCrossRefPubMed
74.
go back to reference Clough-Gorr KM, Silliman RA: Translation Requires Evidence: Does Cancer-Specific CGA Lead to Better Care and Outcomes?. Oncology. 2008, (Williston Park), 22: 925-928. Clough-Gorr KM, Silliman RA: Translation Requires Evidence: Does Cancer-Specific CGA Lead to Better Care and Outcomes?. Oncology. 2008, (Williston Park), 22: 925-928.
75.
go back to reference Spina M, Balzarotti M, Uziel L, Ferreri AJ, Fratino L, Magagnoli M, Talamini R, Giacalone A, Ravaioli E, Chimienti E, Berretta M, Lleshi A, Santoro A, Tirelli U: Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma. Oncologist. 2012, 17 (6): 838-846. 10.1634/theoncologist.2011-0417.PubMedCentralCrossRefPubMed Spina M, Balzarotti M, Uziel L, Ferreri AJ, Fratino L, Magagnoli M, Talamini R, Giacalone A, Ravaioli E, Chimienti E, Berretta M, Lleshi A, Santoro A, Tirelli U: Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma. Oncologist. 2012, 17 (6): 838-846. 10.1634/theoncologist.2011-0417.PubMedCentralCrossRefPubMed
76.
go back to reference Quaglia A, Lillini R, Casella C, Giachero G, Izzotti A, Vercelli M: The combined effect of age and socio-economic status on breast cancer survival. Crit Rev Oncol Hematol. 2011, 77: 210-220. 10.1016/j.critrevonc.2010.02.007. Liguria Region Tumour RegistryCrossRefPubMed Quaglia A, Lillini R, Casella C, Giachero G, Izzotti A, Vercelli M: The combined effect of age and socio-economic status on breast cancer survival. Crit Rev Oncol Hematol. 2011, 77: 210-220. 10.1016/j.critrevonc.2010.02.007. Liguria Region Tumour RegistryCrossRefPubMed
77.
go back to reference Crivellari D, Spazzapan S, Lombardi D, Berretta M, Magri MD, Sorio R, Scalone S, Veronesi A: Treatment of older breast cancer patients with high recurrence risk. Crit Rev Oncol Hematol. 2003, 46: 241-246. 10.1016/S1040-8428(03)00023-4.CrossRefPubMed Crivellari D, Spazzapan S, Lombardi D, Berretta M, Magri MD, Sorio R, Scalone S, Veronesi A: Treatment of older breast cancer patients with high recurrence risk. Crit Rev Oncol Hematol. 2003, 46: 241-246. 10.1016/S1040-8428(03)00023-4.CrossRefPubMed
78.
go back to reference Livi L, Paiar F, Saieva C, Simontacchi G, Nori J, Sanchez L, Santini R, Mangoni M, Fondelli S, Distante V, Bianchi S, Biti G: Breast cancer in the elderly: treatment of 1500 patients. Breast J. 2006, 12: 353-359. 10.1111/j.1075-122X.2006.00275.x.CrossRefPubMed Livi L, Paiar F, Saieva C, Simontacchi G, Nori J, Sanchez L, Santini R, Mangoni M, Fondelli S, Distante V, Bianchi S, Biti G: Breast cancer in the elderly: treatment of 1500 patients. Breast J. 2006, 12: 353-359. 10.1111/j.1075-122X.2006.00275.x.CrossRefPubMed
80.
go back to reference Bouchardy C, Rapiti E, Fioretta G, Laissue P, Neyroud-Caspar I, Schäfer P, Kurtz J, Sappino AP, Vlastos G: Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol. 2003, 21 (19): 3580-3587. 10.1200/JCO.2003.02.046. Oct 1CrossRefPubMed Bouchardy C, Rapiti E, Fioretta G, Laissue P, Neyroud-Caspar I, Schäfer P, Kurtz J, Sappino AP, Vlastos G: Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol. 2003, 21 (19): 3580-3587. 10.1200/JCO.2003.02.046. Oct 1CrossRefPubMed
81.
go back to reference Janssen-Heijnen ML, Maas HA, Houterman S, Lemmens VE, Rutten HJ, Coebergh JW: Comorbidity in older surgical cancer patients: influence on patient care and outcome. European Journal of Cancer. 2007, 43: 2179-2193. 10.1016/j.ejca.2007.06.008.CrossRefPubMed Janssen-Heijnen ML, Maas HA, Houterman S, Lemmens VE, Rutten HJ, Coebergh JW: Comorbidity in older surgical cancer patients: influence on patient care and outcome. European Journal of Cancer. 2007, 43: 2179-2193. 10.1016/j.ejca.2007.06.008.CrossRefPubMed
82.
go back to reference Gajdos C, Tartter PI, Bleiweiss IJ, Lopchinsky RA, Bernstein JL: The consequence of undertreating breast cancer in the elderly. J Am Coll Surg. 2001, 192: 698-707. 10.1016/S1072-7515(01)00832-8.CrossRefPubMed Gajdos C, Tartter PI, Bleiweiss IJ, Lopchinsky RA, Bernstein JL: The consequence of undertreating breast cancer in the elderly. J Am Coll Surg. 2001, 192: 698-707. 10.1016/S1072-7515(01)00832-8.CrossRefPubMed
83.
go back to reference Wang J, Kollias J, Boult M, Babidge W, Zorbas HN, Roder D, Maddern G: Patterns of surgical treatment for women with breast cancer in relation to age. Breast J. 2010, 16: 60-65. 10.1111/j.1524-4741.2009.00828.x.CrossRefPubMed Wang J, Kollias J, Boult M, Babidge W, Zorbas HN, Roder D, Maddern G: Patterns of surgical treatment for women with breast cancer in relation to age. Breast J. 2010, 16: 60-65. 10.1111/j.1524-4741.2009.00828.x.CrossRefPubMed
84.
go back to reference Yood MU, Owusu C, Buist DS, Geiger AM, Field TS, Thwin SS, Lash TL, Prout MN, Wei F, Quinn VP, Frost FJ, Silliman RA: Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg. 2008, 206 (1): 66-75. 10.1016/j.jamcollsurg.2007.07.015. JanCrossRefPubMed Yood MU, Owusu C, Buist DS, Geiger AM, Field TS, Thwin SS, Lash TL, Prout MN, Wei F, Quinn VP, Frost FJ, Silliman RA: Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg. 2008, 206 (1): 66-75. 10.1016/j.jamcollsurg.2007.07.015. JanCrossRefPubMed
85.
go back to reference Wagner JL, Warneke CL, Mittendorf EA, Bedrosian I, Babiera GV, Kuerer HM, Hunt KK, Yang W, Sahin AA, Meric-Bernstam F: Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg. 2011, 254: 119-124. 10.1097/SLA.0b013e318217e97f.PubMedCentralCrossRefPubMed Wagner JL, Warneke CL, Mittendorf EA, Bedrosian I, Babiera GV, Kuerer HM, Hunt KK, Yang W, Sahin AA, Meric-Bernstam F: Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg. 2011, 254: 119-124. 10.1097/SLA.0b013e318217e97f.PubMedCentralCrossRefPubMed
86.
go back to reference Kimmick GG, Muss HB: Systemic therapy for older women with breast cancer. Oncology. 2001, (Williston Park), 15: 280-291. discussion 291-292, 295-296, 299 Kimmick GG, Muss HB: Systemic therapy for older women with breast cancer. Oncology. 2001, (Williston Park), 15: 280-291. discussion 291-292, 295-296, 299
87.
go back to reference Berretta M, Cappellani A, Fiorica F, Nasti G, Frustaci S, Fisichella R, Bearz A, Talamini R, Lleshi A, Tambaro R, Cocciolo A, Ristagno M, Bolognese A, Basile F, Meneguzzo N, Berretta S, Tirelli U: FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients: a prospective study. Arch Gerontol Geriatr. 2011, 52 (1): 89-93. 10.1016/j.archger.2010.02.006. Jan-FebCrossRefPubMed Berretta M, Cappellani A, Fiorica F, Nasti G, Frustaci S, Fisichella R, Bearz A, Talamini R, Lleshi A, Tambaro R, Cocciolo A, Ristagno M, Bolognese A, Basile F, Meneguzzo N, Berretta S, Tirelli U: FOLFOX4 in the treatment of metastatic colorectal cancer in elderly patients: a prospective study. Arch Gerontol Geriatr. 2011, 52 (1): 89-93. 10.1016/j.archger.2010.02.006. Jan-FebCrossRefPubMed
88.
go back to reference Owusu C, Buist DS, Field TS, Lash TL, Thwin SS, Geiger AM, Quinn VP, Frost F, Prout M, Yood MU, Wei F, Silliman RA: Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol. 2008, 25: 549-555.CrossRef Owusu C, Buist DS, Field TS, Lash TL, Thwin SS, Geiger AM, Quinn VP, Frost F, Prout M, Yood MU, Wei F, Silliman RA: Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol. 2008, 25: 549-555.CrossRef
89.
go back to reference Muss HB, Woolf S, Berry D, Cirrincione C, Weiss RB, Budman D, Wood WC, Henderson IC, Hudis C, Winer E, Cohen H, Wheeler J, Norton L: Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA. 2005, 293: 1073-1081. 10.1001/jama.293.9.1073. Cancer and Leukemia Group BCrossRefPubMed Muss HB, Woolf S, Berry D, Cirrincione C, Weiss RB, Budman D, Wood WC, Henderson IC, Hudis C, Winer E, Cohen H, Wheeler J, Norton L: Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA. 2005, 293: 1073-1081. 10.1001/jama.293.9.1073. Cancer and Leukemia Group BCrossRefPubMed
90.
go back to reference Crivellari D, Toffoli G, Lombardi D, Berretta M, Sorio R, Magri MD, Spazzapan S, Scuderi C, Veronesi A: Idarubicin. Tumori. 2002, 88 (1 Suppl 1): S73-S74.PubMed Crivellari D, Toffoli G, Lombardi D, Berretta M, Sorio R, Magri MD, Spazzapan S, Scuderi C, Veronesi A: Idarubicin. Tumori. 2002, 88 (1 Suppl 1): S73-S74.PubMed
91.
go back to reference Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004, 351: 2817-2826. 10.1056/NEJMoa041588.CrossRefPubMed Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004, 351: 2817-2826. 10.1056/NEJMoa041588.CrossRefPubMed
92.
go back to reference Barthélémy P, Heitz D, Mathelin C, Polesi H, Asmane I, Litique V, Rob L, Bergerat JP, Kurtz JE: Adjuvant chemotherapy in elderly patients with earlybreast cancer Impact of age and comprehensive geriatric assessment on tumor board proposals. Crit Rev Oncol Hematol. 2011, 79 (2): 196-204. 10.1016/j.critrevonc.2010.06.005. AugCrossRefPubMed Barthélémy P, Heitz D, Mathelin C, Polesi H, Asmane I, Litique V, Rob L, Bergerat JP, Kurtz JE: Adjuvant chemotherapy in elderly patients with earlybreast cancer Impact of age and comprehensive geriatric assessment on tumor board proposals. Crit Rev Oncol Hematol. 2011, 79 (2): 196-204. 10.1016/j.critrevonc.2010.06.005. AugCrossRefPubMed
Metadata
Title
Prognostic factors in elderly patients with breast cancer
Authors
Alessandro Cappellani
Maria Di Vita
Antonio Zanghì
Andrea Cavallaro
Gaetano Piccolo
Marcello Majorana
Giuseppina Barbera
Massimiliano Berretta
Publication date
01-10-2013
Publisher
BioMed Central
Published in
BMC Surgery / Issue Special Issue 2/2013
Electronic ISSN: 1471-2482
DOI
https://doi.org/10.1186/1471-2482-13-S2-S2

Other articles of this Special Issue 2/2013

BMC Surgery 2/2013 Go to the issue